-
Ionctura Commences Randomized Phase I/II Study In Non-Small Cell Lung Cancer
08 May 2025 09:18 GMT
… dostarlimab +/- docetaxel in patients with NSCLC who … docetaxel, in patients with advanced non-small cell lung cancer … (NSCLC).
NSCLC is the most common type of lung cancer. Lung cancer … dostarlimab, with or without docetaxel. The study will …
-
iOnctura starts randomised phase 1/2 trial in lung cancer treatment
08 May 2025 08:55 GMT
… , with or without docetaxel, in advanced non-small cell lung cancer (NSCLC).
The … the most common type of lung cancer and accounts for around one …
-
Viral immunotherapy confers ‘striking’ survival benefit in advanced lung cancer
05 May 2025 23:34 GMT
… doubled survival compared with docetaxel for patients who had … M. Heisler Professor for Lung Cancer Excellence at University of … of solid tumors, including lung cancer, prostate cancer and … bronchoscopic injection into the lung tumor, positive lymph node or …
-
Zoldonrasib Elicits Objective Responses in Patients With KRAS G12D-mutated Lung Cancer
28 Apr 2025 16:10 GMT
… previously treated non-small cell lung cancer (NSCLC) whose tumors harbored a … NSCLC is typically the chemotherapy docetaxel, which has an objective response … patients with KRAS G12D-mutated lung cancer,” she said. “We’ve shown …
-
AnaptysBio Gears Up For Key Trial Readouts In Rheumatoid Arthritis And Lung Cancer
28 Apr 2025 11:44 GMT
… , and Docetaxel in patients with advanced non-small-cell lung cancer who have …
-
Tislelizumab Significantly Boosts Survival in Lung Cancer Trials
24 Apr 2025 20:42 GMT
… overall survival (OS) across different lung cancer populations, according to findings from … metastatic nonsquamous non-small-cell lung cancer (final analysis of RATIONALE-304 … Y, et al. Tislelizumab versus docetaxel in patients with previously treated …
-
TTFields Therapy Earns EU Approval in Metastatic Non–Small Cell Lung Cancer
23 Apr 2025 20:11 GMT
… inhibitors (ICIs) or docetaxel has received the Conformité … difficult to treat, including lung cancer. We believe the efficacy … 4 non-small cell lung cancer (NSCLC) following platinum failure … of metastatic non-small cell lung cancer. News release. Novocure. …
-
Therapeutic Potential of Datopotamab Deruxtecan in the Treatment of Advanced Non-Small Cell Lung Cancer: Evidence to Date
23 Apr 2025 08:01 GMT
… correlated with increased lung cancer-specific mortality in … docetaxel for previously treated advanced or metastatic non–small cell lung cancer … treated non-small cell lung cancer (NSCLC) with actionable … advanced non-small cell lung cancer (NSCLC), with …
-
Novocure’s Optune Lua® Receives CE Mark Approval for the Treatment of Metastatic Non-Small Cell Lung Cancer
22 Apr 2025 11:37 GMT
… lung cancer (NSCLC) concurrently with immune checkpoint inhibitors or docetaxel … Non-Small Cell Lung Cancer (NSCLC)
Lung cancer is the most … 85% of all lung cancers.i In Europe, … lung cancer: current treatment and future advances. Transl Lung Cancer …
-
Feasibility and Safety of Anlotinib Plus Docetaxel versus Docetaxel Monotherapy in Patients with Previously Immunotherapy-Treated NSCLC: A Retrospective Exploratory Study
28 Apr 2025 08:50 GMT
… anlotinib combined with docetaxel or docetaxel monotherapy as … with anlotinib plus docetaxel or docetaxel therapy. The … docetaxel vs. docetaxel alone for advanced non-small-cell lung cancer … advanced non-small cell lung cancer: a retrospective exploratory …
About
© 1995-2025